Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins

References

1. Androphy E., Hubbert N., Schiller J., Lowy D. 1987; Identification of the HPV-16 E6 protein from transformed cells and human cervical carcinoma cells. EMBO Journal 6:989–992
   [Google Scholar]
2. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. 1987; Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. Journal of General Virology 68:1351–1359
   [Google Scholar]
3. Barbosa M. S., Schlegel R. 1989; The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529–1532
   [Google Scholar]
4. Eckner R., Ewen M. E., Newsome D., Gerdes M., DeCaprio J. A., Lawrence J. B., Livingston D. M. 1994; Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes & Development 8:869–884
   [Google Scholar]
5. Eckner R., Ludlow J. W., Lill N. L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J. A., Livingston D. M., Morgan J. A. 1996; Association of p300 and CBP with simian virus 40 large T antigen. Molecular and Cellular Biology 16:3454–3464
   [Google Scholar]
6. Foster S. A., Demers G. W., Etscheid B. G., Galloway D. A. 1994; The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. Journal of Virology 68:5698–5705
   [Google Scholar]
7. Gardiol D., Kühne C., Glaunsinger B., Lee S. S., Javier R., Banks L. 1999; Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487–5496
   [Google Scholar]
8. Hawley-Nelson P., Vousden K., Hubbert N., Lowy D., Schiller J. 1989; HPV-16 E6 and E7 proteins cooperate to immortalise human foreskin keratinocytes. EMBO Journal 8:3905–3910
   [Google Scholar]
9. Hottiger M. O., Nabel G. J. 1998; Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. Journal of Virology 72:8252–8256
   [Google Scholar]
10. Huibregtse J., Scheffner M., Howley P. 1991; A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO Journal 10:4129–4135
    [Google Scholar]
11. Kessis T. D., Slebos R. J., Nelson W. G., Kastan M. B., Plunkett B. S., Han S. M., Lorincz A. T., Hedrick L., Cho K. R. 1993; Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proceedings of the National Academy of Sciences, USA 90:3988–3992
    [Google Scholar]
12. Korzus E., Torchia J., Rose D. W., Xu L., Kurokawa R., McInerney E. M., Mullen T.-M., Glass C. K., Rosenfeld M. G. 1998; Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703–707
    [Google Scholar]
13. Kurokawa R., Kalafus D., Ogliastro M.-H., Kioussi C., Xu L., Torchia J., Rosenfeld M. G., Glass C. K. 1998; Differential use of CREB binding protein-coactivator complexes. Science 279:700–703
    [Google Scholar]
14. Lane D. 1992; P53: guardian of the genome. Nature 358:15–16
    [Google Scholar]
15. Massimi P., Pim D., Storey A., Banks L. 1996; HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12:2325–2330
    [Google Scholar]
16. Patel D., Huang S.-M., Baglia L. A., McCance D. 1999; The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO Journal 18:5061–5072
    [Google Scholar]
17. Pim D., Storey A., Thomas M., Massimi P., Banks L. 1994; Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9:1869–1876
    [Google Scholar]
18. Pim D., Thomas M., Banks L. 2001; The function of the human papillomavirus oncogenes. In Viruses, Cell Transformation and Cancer pp 145–192 Edited by Grand R. J. A. Amsterdam: Elsevier Science;
    [Google Scholar]
19. Scheffner M., Werness B., Huibregtse J., Levine A., Howley P. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
    [Google Scholar]
20. Schwarz E., Freese U., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
    [Google Scholar]
21. Smith D. H., Ziff E. B. 1988; The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Molecular and Cellular Biology 8:3882–3890
    [Google Scholar]
22. Stein R. W., Corrigan M., Yaciuk P., Whelan J., Moran E. 1990; Analysis of E1A-mediated growth regulation functions: binding of 300 kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. Journal of Virology 64:4421–4427
    [Google Scholar]
23. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. 1988; Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7:1815–1820
    [Google Scholar]
24. Werness B., Levine A., Howley P. 1990; Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79
    [Google Scholar]
25. Whyte P., Ruley H. E., Harlow E. 1988; Two regions of the adenovirus early region 1A proteins are required for transformation. Journal of Virology 62:257–265
    [Google Scholar]
26. Wu X., Levine A. 1994; p53 and E2-F cooperate to mediate apoptosis. Proceedings of the National Academy of Sciences, USA 91:3602–3606
    [Google Scholar]
27. Zimmermann H., Degenkolbe R., Bernard H.-U., O’Connor M. J. 1999; The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. Journal of Virology 73:6209–6219
    [Google Scholar]
28. Zimmermann H., Koh C.-H., Degenkolbe R., O’Connor M. J., Muller A., Steger G., Chen J. J., Liu Y., Androphy E., Bernard H.-U. 2000; Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. Journal of General Virology 81:2617–2623
    [Google Scholar]